Brexpiprazole: A new option in treating agitation in Alzheimer's dementia-Insights from transgenic mouse models.

In the Tg mice, brexpiprazole treatment (0.03 mg/kg) significantly delayed the latency to first attack and showed a trend toward a decrease in attack number.

also in 53,322 other papers